{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:19:06Z","timestamp":1791011946363,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s00467-008-0810-5","type":"journal-article","created":{"date-parts":[[2008,5,26]],"date-time":"2008-05-26T13:27:20Z","timestamp":1211808440000},"page":"1823-1829","source":"Crossref","is-referenced-by-count":54,"title":["Cinacalcet for secondary hyperparathyroidism in children with end-stage renal disease"],"prefix":"10.1007","volume":"23","author":[{"given":"Jutta","family":"Muscheites","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Wigger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdmute","family":"Drueckler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar-Christiane","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenther","family":"Kundt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,10,1]]},"reference":[{"key":"810_CR1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1056\/NEJM197802022980503","volume":"298","author":"RW Chesney","year":"1978","unstructured":"Chesney RW, Moorthy AV, Eisman JA, Jax DK, Mazess RB, DeLuca HF (1978) Increased growth after long-term oral 1alpha,25-vitamin D3 in childhood renal osteodystrophy. N Engl J Med 298:238\u2013242","journal-title":"N Engl J Med"},{"key":"810_CR2","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1093\/oxfordjournals.ndt.a027662","volume":"11","author":"O Mehls","year":"1996","unstructured":"Mehls O, Wuhl E, Haffner D, Schaefer F, Tonshoff B (1996) Growth hormone treatment of short children with chronic renal failure before and after renal transplantation: rationale and recent results. Nephrol Dial Transplant 11:1747\u20131750","journal-title":"Nephrol Dial Transplant"},{"key":"810_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/ki.1997.297","volume":"52","author":"AM Parfitt","year":"1997","unstructured":"Parfitt AM (1997) The hyperparathyroidism of chronic renal failure: a disorder of growth. Kidney Int 52:3\u20139","journal-title":"Kidney Int"},{"key":"810_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0272-6386(12)80977-2","volume":"23","author":"E Slatopolsky","year":"1994","unstructured":"Slatopolsky E, Delmez JA (1994) Pathogenesis of secondary hyperparathyroidism. Am J Kidney Dis 23:229\u2013236","journal-title":"Am J Kidney Dis"},{"key":"810_CR5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/BF00866763","volume":"10","author":"E Wuhl","year":"1996","unstructured":"Wuhl E, Haffner D, Nissel R, Schaefer F, Mehls O (1996) Short dialyzed children respond less to growth hormone than patients prior to dialysis. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Pediatr Nephrol 10:294\u2013298","journal-title":"Pediatr Nephrol"},{"key":"810_CR6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1053\/j.ajkd.2005.12.039","volume":"47","author":"AK Pieper","year":"2006","unstructured":"Pieper AK, Haffner D, Hoppe B, Dittrich K, Offner G, Bonzel KE, John U, Frund S, Klaus G, Stubinger A, Duker G, Querfeld U (2006) A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD. Am J Kidney Dis 47:625\u2013635","journal-title":"Am J Kidney Dis"},{"key":"810_CR7","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1093\/ndt\/gfl098","volume":"21","author":"S Briese","year":"2006","unstructured":"Briese S, Wiesner S, Will JC, Lembcke A, Opgen-Rhein B, Nissel R, Wernecke KD, Andreae J, Haffner D, Querfeld U (2006) Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease\u2014impact of calcium and vitamin D therapy. Nephrol Dial Transplant 21:1906\u20131914","journal-title":"Nephrol Dial Transplant"},{"key":"810_CR8","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","volume":"342","author":"WG Goodman","year":"2000","unstructured":"Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478\u20131483","journal-title":"N Engl J Med"},{"key":"810_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1161\/01.CIR.0000020222.63035.C0","volume":"106","author":"J Oh","year":"2002","unstructured":"Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100\u2013105","journal-title":"Circulation"},{"key":"810_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1046\/j.1523-1755.1998.00724.x","volume":"53","author":"BD Kuizon","year":"1998","unstructured":"Kuizon BD, Goodman WG, Juppner H, Boechat I, Nelson P, Gales B, Salusky IB (1998) Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD. Kidney Int 53:205\u2013211","journal-title":"Kidney Int"},{"key":"810_CR11","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1073\/pnas.95.7.4040","volume":"95","author":"EF Nemeth","year":"1998","unstructured":"Nemeth EF, Steffey ME, Hammerland LG, Hung BC, Van Wagenen BC, DelMar EG, Balandrin MF (1998) Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci U\u00a0S\u00a0A 95:4040\u20134045","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"810_CR12","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1056\/NEJMoa031633","volume":"350","author":"GA Block","year":"2004","unstructured":"Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drueke TB, Goodman WG (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350:1516\u20131525","journal-title":"N Engl J Med"},{"key":"810_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2215\/CJN.00870805","volume":"1","author":"GM Chertow","year":"2006","unstructured":"Chertow GM, Blumenthal S, Turner S, Roppolo M, Stern L, Chi EM, Reed J (2006) Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium \u00d7 phosphate. Clin J Am Soc Nephrol 1:305\u2013312","journal-title":"Clin J Am Soc Nephrol"},{"key":"810_CR14","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/01.tp.0000253429.33198.2f","volume":"83","author":"JM El-Amm","year":"2007","unstructured":"El-Amm JM, Doshi MD, Singh A, Migdal S, Morawski K, Sternbauer D, Cincotta E, West MS, Losanoff JE, Gruber SA (2007) Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation. Transplantation 83:546\u2013549","journal-title":"Transplantation"},{"key":"810_CR15","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1681\/ASN.V1341017","volume":"13","author":"WG Goodman","year":"2002","unstructured":"Goodman WG, Hladik GA, Turner SA, Blaisdell PW, Goodkin DA, Liu W, Barri YM, Cohen RM, Coburn JW (2002) The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol 13:1017\u20131024","journal-title":"J Am Soc Nephrol"},{"key":"810_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1046\/j.1523-1755.2003.00720.x","volume":"63","author":"JS Lindberg","year":"2003","unstructured":"Lindberg JS, Moe SM, Goodman WG, Coburn JW, Sprague SM, Liu W, Blaisdell PW, Brenner RM, Turner SA, Martin KJ (2003) The calcimimetic AMG 073 reduces parathyroid hormone and calcium \u00d7 phosphorus in secondary hyperparathyroidism. Kidney Int 63:248\u2013254","journal-title":"Kidney Int"},{"key":"810_CR17","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1523-1755.2005.00517.x","volume":"68","author":"KJ Martin","year":"2005","unstructured":"Martin KJ, Juppner H, Sherrard DJ, Goodman WG, Kaplan MR, Nassar G, Campbell P, Curzi M, Charytan C, McCary LC, Guo MD, Turner SA, Bushinsky DA (2005) First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl. Kidney Int 68:1236\u20131243","journal-title":"Kidney Int"},{"key":"810_CR18","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1093\/ndt\/gfh966","volume":"20","author":"SM Moe","year":"2005","unstructured":"Moe SM, Cunningham J, Bommer J, Adler S, Rosansky SJ, Urena-Torres P, Albizem MB, Guo MD, Zani VJ, Goodman WG, Sprague SM (2005) Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl. Nephrol Dial Transplant 20:2186\u20132193","journal-title":"Nephrol Dial Transplant"},{"key":"810_CR19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/01.ASN.0000050224.03126.AD","volume":"14","author":"LD Quarles","year":"2003","unstructured":"Quarles LD, Sherrard DJ, Adler S, Rosansky SJ, McCary LC, Liu W, Turner SA, Bushinsky DA (2003) The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease. J Am Soc Nephrol 14:575\u2013583","journal-title":"J Am Soc Nephrol"},{"key":"810_CR20","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/ndt\/gfl560","volume":"22","author":"AL Serra","year":"2007","unstructured":"Serra AL, Savoca R, Huber AR, Hepp U, Delsignore A, Hersberger M, Wuthrich RP (2007) Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients. Nephrol Dial Transplant 22:577\u2013583","journal-title":"Nephrol Dial Transplant"},{"key":"810_CR21","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/01.tp.0000232452.80018.ad","volume":"82","author":"I Szwarc","year":"2006","unstructured":"Szwarc I, Argiles A, Garrigue V, Delmas S, Chong G, Deleuze S, Mourad G (2006) Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism. Transplantation 82:675\u2013680","journal-title":"Transplantation"},{"key":"810_CR22","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1007\/s00467-003-1290-2","volume":"18","author":"WG Goodman","year":"2003","unstructured":"Goodman WG (2003) Calcimimetic agents and secondary hyperparathyroidism: rationale for use and results from clinical trials. Pediatr Nephrol 18:1206\u20131210","journal-title":"Pediatr Nephrol"},{"key":"810_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jcp.32.1.56","volume":"32","author":"RB Payne","year":"1979","unstructured":"Payne RB, Carver ME, Morgan DB (1979) Interpretation of serum total calcium: effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual. J Clin Pathol 32:56\u201360","journal-title":"J Clin Pathol"},{"key":"810_CR24","first-page":"1","volume":"46","author":"CB Langman","year":"2005","unstructured":"Langman CB, Salusky IB, Greenbaum L, Jueppner H, Leonard M, Nelson P, Portale A, Warady BA (2005) K\/DOQI Clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 46:1\u2013121","journal-title":"Am J Kidney Dis"},{"key":"810_CR25","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1172\/JCI119491","volume":"99","author":"T Ishizuya","year":"1997","unstructured":"Ishizuya T, Yokose S, Hori M, Noda T, Suda T, Yoshiki S, Yamaguchi A (1997) Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest 99:2961\u20132970","journal-title":"J Clin Invest"},{"key":"810_CR26","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1046\/j.1523-1755.2000.00993.x","volume":"57","author":"CP Schmitt","year":"2000","unstructured":"Schmitt CP, Hessing S, Oh J, Weber L, Ochlich P, Mehls O (2000) Intermittent administration of parathyroid hormone (1\u201337) improves growth and bone mineral density in uremic rats. Kidney Int 57:1484\u20131492","journal-title":"Kidney Int"},{"key":"810_CR27","doi-asserted-by":"publisher","first-page":"48A","DOI":"10.1097\/01.ASN.0000068162.02174.29","volume":"14","author":"M Wada","year":"2003","unstructured":"Wada M, Furuya Y, Kobayashi N, Kobayashi N, Miyata S, Ishii H, Nagano N (2003) The calcimimetic compound AMG 073 (cinacalcet HCl) ameliorates osteitis fibrosa in rats with chronic renal insufficiency. J Am Soc Nephrol 14:48A","journal-title":"J Am Soc Nephrol"},{"key":"810_CR28","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1046\/j.1523-1755.2002.00616.x","volume":"62","author":"M Daschner","year":"2002","unstructured":"Daschner M, Philippin B, Nguyen T, Wiesner RJ, Walz C, Oh J, Sandow J, Mehls O, Schaefer F (2002) Circulating inhibitor of gonadotropin releasing hormone secretion by hypothalamic neurons in uremia. Kidney Int 62:1582\u20131590","journal-title":"Kidney Int"},{"key":"810_CR29","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1056\/NEJM200009283431304","volume":"343","author":"D Haffner","year":"2000","unstructured":"Haffner D, Schaefer F, Nissel R, Wuhl E, Tonshoff B, Mehls O (2000) Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. N Engl J Med 343:923\u2013930","journal-title":"N Engl J Med"},{"key":"810_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1203\/00006450-199007000-00002","volume":"28","author":"F Schaefer","year":"1990","unstructured":"Schaefer F, Seidel C, Binding A, Gasser T, Largo RH, Prader A, Scharer K (1990) Pubertal growth in chronic renal failure. Pediatr Res 28:5\u201310","journal-title":"Pediatr Res"},{"key":"810_CR31","doi-asserted-by":"publisher","first-page":"132A","DOI":"10.1681\/ASN.2005070759","volume":"17","author":"K Nakagawa","year":"2006","unstructured":"Nakagawa K, Geldyyev A, Oh J, Gross ML, Santos F, Schaefer F, Schmitt CP (2006) Calcimimetics do not alter epiphyseal growth in healthy and uremic rats. J Am Soc Nephrol 17:132A","journal-title":"J Am Soc Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-008-0810-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-008-0810-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-008-0810-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-008-0810-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T05:11:38Z","timestamp":1631337098000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-008-0810-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["810"],"URL":"https:\/\/doi.org\/10.1007\/s00467-008-0810-5","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}